Feb 9, 2006 by Jason Mac GurnRNA: Rule Breaker Nucleic AcidNew RNA-based technologies may be the next revolution in biopharmaceuticals.
Jan 12, 2006 by Jason Mac GurnMine Safety's "Mad Money" BoostStock-pickers can pump up the price of a stock, but make sure you know the value of the business before you jump in.
Nov 7, 2005 by Jason Mac GurnMine Safety Hits a Speed BumpWeak third-quarter results are an indication that Mine Safety needs to diversify its business.
Nov 1, 2005 by Jason Mac GurnDucommun Halts DescentDucommun's improving profit margins are encouraging, but not quite gem-like.
Oct 25, 2005 by Jason Mac GurnVisualizing Value for FlamelRemember this Foolish mantra for biotech investing: Don't pay for anybody's dreams.
Oct 14, 2005 by Jason Mac GurnDucommun Spins Its PropellersCompanies with a weak customer base can exhibit margin decay. Just ask Ducommun.
Oct 5, 2005 by Jason Mac GurnMine Safety Goes BallisticEntering the body armor market can only help the firm's top line.
